Artemisia annua and A. afra Teas, Artemisinin, and Dihydroartemisinin Differentially Regulate ROS and Fibrosis-Associated Phenotypes in Human Dermal Fibroblasts
Molecules · 07.08.2026 · 31 (16) · 2745
DOI: 10.3390/molecules31162745 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 07.08.2026. Verfasst von Samuel Isife und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biotechnology, Worcester Polytechnic Institute, 100 Institute Rd., Worcester, MA 01609, USA. Hauptthemen laut MEDLINE: Artemisinins, Artemisia annua, Fibroblasts, Reactive Oxygen Species. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCIH NIH HHS, Ararat Fund, National Center for Complementary and Integrative Health.
Abstract (Originalsprache)
Fibrosis is driven by persistent fibroblast activation, oxidative stress, myofibroblast differentiation, and extracellular matrix remodeling, yet available antifibrotic therapies remain limited. This study evaluated whether artemisinin (ART), dihydroartemisinin (DHA), and traditional tea infusions of Artemisia annua and A. afra differentially regulate fibrosis-associated responses in human dermal fibroblasts. Neonatal and adult human dermal fibroblasts were cultured under pre-fibrotic or TGF-β/ascorbic acid-stimulated pro-fibrotic conditions and assessed for intracellular ROS, scratch-wound closure, collagen gel contraction, fibrosis-associated gene expression, and α-SMA protein abundance. Artemisia teas produced greater ROS reduction than purified ART or DHA, with A. afra showing the strongest antioxidant effect despite lacking detectable artemisinin. DHA and A. annua most consistently suppressed scratch closure, while A. afra produced intermediate inhibition and ART was comparable to vehicle control. Collagen gel contraction was most strongly reduced by A. annua, with DHA and A. afra producing intermediate suppression. Under pro-fibrotic conditions, DHA and A. annua downregulated ACTA2, A. annua suppressed COL1A1, and DHA and A. annua increased matrix-remodeling MMP expression. Reduced levels of α-SMA confirmed the antifibrotic effects. These findings indicate that antifibrotic activity differs among artemisinin-related compounds and whole-plant Artemisia preparations, with DHA and A. annua showing the strongest overall activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Biotechnology, Worcester Polytechnic Institute, 100 Institute Rd., Worcester, MA 01609, USA.
- Department of Biomedical Engineering, Worcester Polytechnic Institute, 100 Institute Rd., Worcester, MA 01609, USA.
ORCID-Profile: Samuel Isife, Pamela Weathers
Förderung
- NCCIH NIH HHS
- Ararat Fund
- National Center for Complementary and Integrative Health
Zitieren
APA
Isife, S., Bush, T., Medasani, I., Towler, M., & Weathers, P. (2026). Artemisia annua and A. afra Teas, Artemisinin, and Dihydroartemisinin Differentially Regulate ROS and Fibrosis-Associated Phenotypes in Human Dermal Fibroblasts. Molecules, 31(16), 2745. https://doi.org/10.3390/molecules31162745
Vancouver
Isife S, Bush T, Medasani I, Towler M, Weathers P. Artemisia annua and A. afra Teas, Artemisinin, and Dihydroartemisinin Differentially Regulate ROS and Fibrosis-Associated Phenotypes in Human Dermal Fibroblasts. Molecules. 2026;31(16):2745. doi:10.3390/molecules31162745
BibTeX
@article{Isife2026,
author = {Isife, Samuel and Bush, Trevor and Medasani, Isha and Towler, Melissa and Weathers, Pamela},
title = {Artemisia annua and A. afra Teas, Artemisinin, and Dihydroartemisinin Differentially Regulate ROS and Fibrosis-Associated Phenotypes in Human Dermal Fibroblasts},
journal = {Molecules},
year = {2026},
volume = {31},
number = {16},
pages = {2745},
doi = {10.3390/molecules31162745}
}
EUVIMED